Found: 13
Select item for more details and to access through your institution.
Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 190, doi. 10.3390/ijms25010190
- By:
- Publication type:
- Article
Dynamic contrast-enhanced MRI in malignant pleural mesothelioma: prediction of outcome based on DCE-MRI measurements in patients undergoing cytotoxic chemotherapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Serum Calretinin as a Biomarker in Malignant Mesothelioma.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 4875, doi. 10.3390/jcm10214875
- By:
- Publication type:
- Article
Extracellular Vesicle Enriched miR-625-3p Is Associated with Survival of Malignant Mesothelioma Patients.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 10, p. 1014, doi. 10.3390/jpm11101014
- By:
- Publication type:
- Article
Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/1242964
- By:
- Publication type:
- Article
Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Učinkovitost kanabinoidov pri zdravljenju raka - mit ali resnica?
- Published in:
- Onkologija, 2018, v. 22, n. 1, p. 8, doi. 10.25670/oi2018-001on
- By:
- Publication type:
- Article
Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma.
- Published in:
- Disease Markers, 2017, p. 1, doi. 10.1155/2017/8069529
- By:
- Publication type:
- Article
Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma.
- Published in:
- Scientific Reports, 2017, p. 46537, doi. 10.1038/srep46537
- By:
- Publication type:
- Article
Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.
- Published in:
- Disease Markers, 2015, p. 1, doi. 10.1155/2015/316739
- By:
- Publication type:
- Article
HOMOLOGOUS RECOMBINATION REPAIR POLYMORPHISMS AND THE RISK FOR OSTEOSARCOMA.
- Published in:
- Journal of Medical Biochemistry, 2015, v. 34, n. 2, p. 200, doi. 10.2478/jomb-2014-0031
- By:
- Publication type:
- Article
Is survivin expression prognostic or predictive in malignant pleural mesothelioma?
- Published in:
- Virchows Archiv: European Journal of Pathology, 2013, v. 462, n. 3, p. 315, doi. 10.1007/s00428-013-1373-9
- By:
- Publication type:
- Article
Exploratory thoracotomy and its influence on the survival of patients with lung cancer.
- Published in:
- Wiener Klinische Wochenschrift, 2006, v. 118, n. 15/16, p. 479, doi. 10.1007/s00508-006-0638-6
- By:
- Publication type:
- Article